C. Michael Gibson, MD

home / authors / c-michael-gibson-md

Articles

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

October 26th 2022

Drs C. Michael Gibson, Ashgan A. Elshinawy, and Nathaniel F. Watson share resources for the treatment of sleep disorders.

Unmet Needs in Sleep Disorder Management

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

October 26th 2022

Nathaniel F. Watson, MD, leads a discussion on gaps in care and unmet needs for patients and healthcare professionals in the area of sleep disorders.

Emerging Treatment Options for Sleep Disorders

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

October 26th 2022

Experts in sleep medicine share emerging treatments in the pipeline for the management of sleep disorders.

Treatment Adherence in Sleep Disorders

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

October 24th 2022

Drs C. Michael Gibson, Ashgan A. Elshinawy, and Nathaniel F. Watson examine setting treatment expectations with patients and treatment adherence for sleep disorders.

Selecting Specific DORAs for Insomnia

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

October 24th 2022

Ashgan A. Elshinawy, DO, shares her approach to treatment selection of DORAs and switching therapies for the management of sleep disorders.

Phase 3 Studies With Daridorexant for Insomnia Management

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

October 21st 2022

Nathaniel F. Watson, MD, highlights the use of daridorexant for treating patients with insomnia as seen from phase 3 trials and data presented at the World Sleep 2022 meeting and managing adverse events.

FDA-Approved Therapies for the Management of Sleep Disorders

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

October 21st 2022

Drs Ashgan A. Elshinawy, C. Michael Gibson, and Nathaniel F. Watson discuss FDA-approved medications currently used for the treatment of sleep disorders and insomnia, and comment on the difference between DORAs.

Sleep Disorders: Sleep and Wakefulness Pathways

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

October 19th 2022

Nathaniel F. Watson, MD, reviews the pathways involved in sleep and wakefulness cycles as it relates to sleep disorders.

Treatment Selection for Sleep Disorders

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

October 19th 2022

Dr Ashgan A. Elshinawy and C. Michael Gibson considers safety and efficacy factors when approaching treatment selection for sleep disorders and insomnia.

Role of Patient Communication in Sleep Disorder Management

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

October 17th 2022

Ashgan A. Elshinawy, DO, comments on engaging patients in conversations around managing sleep disorders with co-occurring health conditions.

Approaching Diagnosis and Treatment of Sleep Disorders and Co-occurring Health Conditions

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

October 17th 2022

Experts in sleep medicine stress the importance of early diagnosis of sleep disorders and how they approach treatment in their clinics.

Screening for Sleep Disorders

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

October 14th 2022

Dr Nathaniel F. Watson reviews screening patients for sleep disorders and referral to sleep specialists.

Complications of Sleep Disorders and Impact on Quality of Life

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

October 14th 2022

Nathaniel F. Watson, MD; Ashgan A. Elshinawy, DO; and C. Michael Gibson, MD, examine complications patients encounter with sleep disorders, including for insomnia, and the impact on their quality of life.

Co-occurrence of Sleep Disorders With Other Health Conditions

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

October 12th 2022

Ashgan A. Elshinawy, DO, leads a discussion on the co-occurrence and relationship between sleep disorders and different health conditions in patients.

Overview of Sleep Disorders

C. Michael Gibson, MD;Ashgan Elshinawy, DO;Nathaniel F. Watson, MD

October 12th 2022

Dr Nathaniel F. Watson, MD, provides insight on the prevalence of various sleep disorders, including insomnia, and patient populations at high-risk for developing these disorders.